In our laboratory, we specialize in the development and enhancement of a microfluidic biochip—an advanced point-of-care device designed to identify various strains of bacterial meningitis. Our focus encompasses detecting strains such as Streptococcus pneumonia, Neisseria meningitides, Haemophilus influenza, among others. Our mission is to optimize the efficiency of detection and ensure accessibility, particularly in low-resource areas.